Dolby Laboratories (NYSE: DLB) stock closed at 99.61 per share at the end of the most recent trading day (a -1.58% change compared to the prior day closing price) with a volume of 529.66K shares and market capitalization of 10.12B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Software industry, Technology sector and employs 2289 people. Dolby Laboratories CEO is Kevin J. Yeaman.

The one-year performance of Dolby Laboratories stock is 72.98%, while year-to-date (YTD) performance is 2.55%. DLB stock has a five-year performance of 137.52%. Its 52-week range is between 52.13 and 103.88, which gives DLB stock a 52-week price range ratio of 91.75%

Dolby Laboratories currently has a PE ratio of 33.10, a price-to-book (PB) ratio of 4.04, a price-to-sale (PS) ratio of 7.30, a price to cashflow ratio of 26.70, a PEG ratio of 2.32, a ROA of 10.17%, a ROC of 12.27% and a ROE of 12.45%. The company’s profit margin is 26.14%, its EBITDA margin is 35.30%, and its revenue ttm is $907.97 Million , which makes it $13.87 revenue per share.

Of the last four earnings reports from Dolby Laboratories, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.47 for the next earnings report. Dolby Laboratories’s next earnings report date is 03rd May 2021.

The consensus rating of Wall Street analysts for Dolby Laboratories is Strong Buy (1.2), with a target price of $109, which is +9.43% compared to the current price. The earnings rating for Dolby Laboratories stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Dolby Laboratories has a dividend yield of 0.87% with a dividend per share of $0.88 and a payout ratio of 39.00%.

Dolby Laboratories has a Buy technical analysis rating based on Technical Indicators (ADX : 8.31, ATR14 : 2.44, CCI20 : 43.27, Chaikin Money Flow : -0.01, MACD : 2.00, Money Flow Index : 44.70, ROC : 2.52, RSI : 56.40, STOCH (14,3) : 62.34, STOCH RSI : 0.14, UO : 44.21, Williams %R : -37.66), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Dolby Laboratories in the last 12-months were: Andy Sherman (Option Excercise at a value of $4 518 986), Andy Sherman (Sold 108 703 shares of value $9 428 119 ), Avadis Tevanian (Sold 1 814 shares of value $163 260 ), Giles Baker (Option Excercise at a value of $6 291 115), Giles Baker (Sold 150 538 shares of value $13 249 552 ), Kevin J. Yeaman (Option Excercise at a value of $12 389 340), Kevin J. Yeaman (Sold 379 931 shares of value $29 471 766 ), Lewis Chew (Option Excercise at a value of $4 210 437), Lewis Chew (Sold 107 152 shares of value $8 559 274 ), N. William Jasper (Sold 3 627 shares of value $327 643 ), Peter Gotcher (Sold 8 004 shares of value $699 718 ), Ryan Nicholson (Option Excercise at a value of $11 155), Ryan Nicholson (Sold 3 138 shares of value $267 239 ), Steve Forshay (Option Excercise at a value of $3 615 561), Steve Forshay (Sold 59 359 shares of value $4 632 096 ), Todd Pendleton (Option Excercise at a value of $3 586 658), Todd Pendleton (Sold 61 101 shares of value $5 590 792 )